Anti-Cancer Potential of MAPK Pathway Inhibition in Paragangliomas–Effect of Different Statins on Mouse Pheochromocytoma Cells
Stephanie Fliedner(University Hospital Schleswig-Holstein), Karel Pacák(Endocrine Society)
Cited by 35
Related Papers
Cushing’s Syndrome Due to Ectopic Corticotropin Secretion: Twenty Years’ Experience at the National Institutes of Health
|The Journal of Clinical Endocrinology & Metabolism|2005|711
Somatic<i>HIF2A</i>Gain-of-Function Mutations in Paraganglioma with Polycythemia
|New England Journal of Medicine|2012|391
Current Approaches and Recommended Algorithm for the Diagnostic Localization of Pheochromocytoma
|The Journal of Clinical Endocrinology & Metabolism|2004|332
The optimal imaging of adrenal tumours: a comparison of different methods
|Endocrine Related Cancer|2007|267
Superiority of 6-[<sup>18</sup>F]-Fluorodopamine Positron Emission Tomography<i>Versus</i>[<sup>131</sup>I]-Metaiodobenzylguanidine Scintigraphy in the Localization of Metastatic Pheochromocytoma
|The Journal of Clinical Endocrinology & Metabolism|2003|240